Select Medical Holdings Corporation (SEM) analyst actions
Rating and price-target actions on SEM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SEM overview →
3 measured SEM analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| $SEM Merger Investigation Initiated: Select Medical Investors Notified of the Pending Investigation into the $16.50 Acquisition Announcement | Press release | +0.00% | +0.06% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Select Medical Holdings Corp. (SEM) And Encourages Shareholders to Reach Out | Press release | +0.03% | +0.00% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Select Medical Holdings Corp. (SEM) And Encourages Stockholders to Reach Out | Press release | +0.00% | +0.09% |
Keep exploring
More SEM: earnings → · SEC filings → · SEM overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RA PHARMACEUTICALS (RARX) | 391 | -0.04% | 45% |
| Checkpoint Therapeutics, Inc. (CKPT) | 389 | 0.00% | 49% |
| PhaseBio Pharmaceuticals, Inc. (PHAS) | 385 | 0.00% | 48% |
| ARADIGM CORP COMMON STOCK (ARDM) | 384 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.